AFJKU - Aimei Health Techn... Stock Analysis | Stock Taper
Logo
Aimei Health Technology Co., Ltd Unit

AFJKU

Aimei Health Technology Co., Ltd Unit NASDAQ
$17.71 -36.77% (-10.30)

Market Cap $46.06 M
52w High $80.00
52w Low $7.60
P/E 0
Volume 1
Outstanding Shares 7.23M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $0 $61.98K $45.44K 0% $0.01 $-61.98K
Q4-2025 $0 $250.59K $98.12K 0% $0.02 $-250.59K
Q3-2025 $0 $130.15K $352.02K 0% $0.06 $-130.15K
Q2-2025 $0 $41.6K $424.97K 0% $0.07 $-41.6K
Q1-2025 $0 $413.41K $184.66K 0% $0.02 $-413.41K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $18.52K $12.29M $4.21M $8.09M
Q4-2025 $2.93K $12.1M $4.06M $8.04M
Q3-2025 $2.98K $45.47M $3.46M $42M
Q2-2025 $2.14K $44.56M $2.9M $41.65M
Q1-2025 $7.34K $43.6M $2.38M $41.23M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $45.44K $-74.61K $-68.66K $158.86K $15.59K $-74.61K
Q4-2025 $98.12K $-43.23K $33.69M $-33.65M $-50 $-43.23K
Q3-2025 $352.02K $-96.11K $-450K $546.95K $841 $-96.11K
Q2-2025 $424.97K $-201.75K $-450K $646.54K $-5.21K $-201.75K
Q1-2025 $184.66K $-224.01K $30.79M $-30.58M $-20.86K $-224.01K

5-Year Trend Analysis

A comprehensive look at Aimei Health Technology Co., Ltd Unit's financial evolution and strategic trajectory over the past five years.

+ Strengths

AFJKU benefits from having raised capital in public markets, operating with no conventional debt and a structure designed to bring a private company public. It has posted accounting profits thanks to non-operating items, holds a substantial base of non-current assets, and faces no immediate burden from interest payments or capital expenditure commitments. The SPAC format can be attractive to a private company seeking a faster or more flexible route to listing.

! Risks

The main risks stem from the absence of a real operating business, zero revenue, and negative operating and free cash flow. Liquidity at the corporate level appears thin relative to current obligations, while shareholder equity and retained earnings are firmly negative, pointing to a fragile capital structure. Competitive and regulatory pressures in the SPAC space, the possibility of investor redemptions, and uncertainty about the eventual target all add significant execution and business risk.

Outlook

The outlook is highly dependent on whether AFJKU can successfully identify, negotiate, and close a high-quality merger, and then on how that combined business performs. Until then, financial statements mainly reflect a transient SPAC structure rather than a going concern with stable revenues and cash flows. Future assessments should focus less on the current shell and more on the fundamentals, strategy, and competitive position of whatever operating company ultimately merges into AFJKU.